Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Nucleic Acids Research
|
September 23, 2021
OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers
Yangjun Zhang, Xiangyang Yao, Hui Zhou, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 21, 2020
HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
Guoliang Sun, Hui Zhou, Ke Chen, et al.
Journal of Cancer
|
July 11, 2019
The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy
Heng Li, Zhize Wang, Yucong Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2023
Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
Guoliang Sun, Hui Zhou, Ke Chen, et al.
Theranostics
|
January 6, 2022
Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum
Libin Yan, Beichen Ding, Haoran Liu, et al.
Theranostics
|
January 6, 2022
Erratum: Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum
Haoran Liu, Xiaoqi Yang, Kun Tang, et al.
American Journal of Physiology. Renal Physiology
|
May 16, 2019
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis
Zhiqiang Chen, Peng Yuan, Xifeng Sun, et al.
Frontiers in Molecular Biosciences
|
June 14, 2021
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma <i>via</i> Promoting Proliferation and Epithelial-Mesenchymal Transition
Guoliang Sun, Yue Ge, Yangjun Zhang, et al.
Theranostics
|
November 23, 2019
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma
Libin Yan, Beichen Ding, Haoran Liu, et al.
Frontiers in Molecular Biosciences
|
November 21, 2022
Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma <i>via</i> promoting proliferation and epithelial-mesenchymal transition
Guoliang Sun, Yue Ge, Yangjun Zhang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Nucleic Acids Research
|
September 23, 2021
OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers
Yangjun Zhang, Xiangyang Yao, Hui Zhou, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 21, 2020
HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
Guoliang Sun, Hui Zhou, Ke Chen, et al.
Journal of Cancer
|
July 11, 2019
The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy
Heng Li, Zhize Wang, Yucong Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2023
Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
Guoliang Sun, Hui Zhou, Ke Chen, et al.
Theranostics
|
January 6, 2022
Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum
Libin Yan, Beichen Ding, Haoran Liu, et al.
Theranostics
|
January 6, 2022
Erratum: Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum
Haoran Liu, Xiaoqi Yang, Kun Tang, et al.
American Journal of Physiology. Renal Physiology
|
May 16, 2019
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis
Zhiqiang Chen, Peng Yuan, Xifeng Sun, et al.
Frontiers in Molecular Biosciences
|
June 14, 2021
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma <i>via</i> Promoting Proliferation and Epithelial-Mesenchymal Transition
Guoliang Sun, Yue Ge, Yangjun Zhang, et al.
Theranostics
|
November 23, 2019
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma
Libin Yan, Beichen Ding, Haoran Liu, et al.
Frontiers in Molecular Biosciences
|
November 21, 2022
Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma <i>via</i> promoting proliferation and epithelial-mesenchymal transition
Guoliang Sun, Yue Ge, Yangjun Zhang, et al.
Page
of 5